{
    "Case ID": "054870",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "cause_of_action": [
                "Improper listing of Wyeth's 778 Patent"
            ],
            "relevant_statute": [
                "Section 8 of the PMNOC Regulations"
            ],
            "application_details": [
                "Ratiopharm's loss period is from January 10, 2006, to August 1, 2007"
            ],
            "evidence_presented": [
                "expert testimony and factual evidence"
            ],
            "decision_reasoning": [
                "Ratiopharm would have occupied part of the generic Venlafaxine market but for the delay"
            ],
            "result_of_case": [
                "Judgment for plaintiff Ratiopharm (now Teva Canada Limited) with specific damage calculations pending"
            ],
            "procedure_followed": [
                "Federal Court trial involving extensive expert testimony on market dynamics, pricing, and regulatory processes"
            ]
        }
    ]
}